Investors Urged to Act Following Class Action Against CAPR
Investors Encouraged to Take Action Against Capricor Therapeutics
Bragar Eagel & Squire, P.C. is reaching out to investors who may have suffered losses due to recent developments with Capricor Therapeutics (CAPR). Individuals who purchased or acquired securities during the specified class period are urged to connect with the firm's litigation partner, Brandon Walker, to explore their legal options.
Details of the Class Action Lawsuit
Capricor Therapeutics has recently been the subject of a class action lawsuit filed in the United States District Court Southern District of California. This action pertains to investors who acquired Capricor securities from October 9, 2024, through July 10, 2025. Investors with an interest in joining the lawsuit are advised to respond before the court’s deadline.
Why the Lawsuit?
Recent statements from Capricor regarding their lead cell therapy candidate, deramiocel, for treating cardiomyopathy associated with Duchenne muscular dystrophy (DMD), raised concerns among investors. The firm had communicated optimistic expectations regarding obtaining a Biologics License Application (BLA) from the FDA. However, these statements failed to disclose potential adverse issues related to the drug's safety and efficacy data from their Phase 2 HOPE-2 trial.
The Impact on Shareholders
On July 11, 2025, Capricor disclosed it received a Complete Response Letter from the FDA rejecting the BLA, emphasizing that the company did not meet the requirements for substantial evidence of effectiveness. This announcement significantly affected shareholder value, causing the stock price to plummet from $11.40 to $7.64 in just one day.
Understanding Your Rights as an Investor
If you are an investor who has suffered a loss in your investment due to the recent events with Capricor, it is imperative to understand your rights. The law firm Bragar Eagel & Squire encourages investors to reach out for a consultation, providing crucial information about the claims and potential recovery processes. Whether you are a long-term stockholder, have useful information, or are simply seeking clarity on your rights, the firm is available to assist you.
Contacting the Right People for Help
Investors can directly contact Brandon Walker or Marion Passmore at (212) 355-4648. The legal team can help guide affected investors through the next steps. Additionally, all inquiries can be sent via email, allowing for a convenient method to seek advice and representation without any upfront costs.
About Bragar Eagel & Squire, P.C.
This firm is recognized nationally for advocating the rights of stockholders, representing them in various complex litigation cases. Most importantly, the firm provides intense dedication to matters concerning securities law, ensuring investors can navigate legal challenges effectively.
Stay Updated on Important Developments
As the situation with Capricor continues to evolve, staying informed is vital. Investors are encouraged to monitor news and updates related to this lawsuit and Capricor’s ongoing status with the FDA. Knowledge is power, and being informed can help investors make the best decisions for their financial future.
Frequently Asked Questions
1. What is the class action lawsuit against Capricor?
The lawsuit is filed on behalf of investors who acquired Capricor securities within a specified time as they experienced financial losses due to misleading information from the company.
2. How do I know if I am eligible to join the lawsuit?
If you bought shares between October 9, 2024, and July 10, 2025, you may be eligible to join the class action and are encouraged to seek advice from a legal expert.
3. What should I do if I incurred losses from my investment in Capricor?
It’s recommended to contact an attorney experienced in securities law to understand your rights and potential paths for recovery.
4. Who can I contact for more information?
You can reach Brandon Walker or Marion Passmore at the provided phone number for personalized support and information.
5. Will it cost me anything to consult with Bragar Eagel & Squire?
No, there is no cost or obligation for initial consultations regarding your legal options concerning this lawsuit.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.